El EMCDDA descubrió que la  pandemia del coronavirus ha afectado la disponibilidad y demanda de servicios relacionados con drogas debido a la introducción de restricciones, distanciamiento físico, y políticas que limitan los servicios no referidos a emergencias. Más información, en inglés, está disponible abajo.


Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments. To investigate the effects of the pandemic on and the implications for drug markets and people who use drugs in the European Neighbourhood Policy (ENP) countries, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launched a trendspotter study. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug markets and people who use drugs in south ENP countries (between March and June 2020).